Ablate and pace revisited: long term survival & predictors of permanent atrial fibrillation

Research output: Contribution to journalArticle

Standard

Ablate and pace revisited: long term survival & predictors of permanent atrial fibrillation. / Queiroga, Andre; Marshall, Howard; Clune, Mairead; Gammage, Michael.

In: Heart, Vol. 89, No. 9, 01.09.2003, p. 1035-1038.

Research output: Contribution to journalArticle

Harvard

APA

Vancouver

Author

Bibtex

@article{f6356b0bd0d044c899efce62e9bc362d,
title = "Ablate and pace revisited: long term survival & predictors of permanent atrial fibrillation",
abstract = "Objective: To assess long term mortality and identify factors associated with the development of permanent atrial fibrillation after atrioventricular (AV) node ablation for drug refractory paroxysmal atrial fibrillation. Design: Retrospective cohort study. Setting: UK tertiary centre teaching hospital. Patients: Patients admitted to the University Hospital Birmingham between January 1995 and December 2000. Interventions: AV node ablation and dual chamber mode switching pacing. Main outcome measures: Long term mortality and predictors of permanent atrial fibrillation, assessed through Kaplan-Meier curves and logistic regression. Results: 114 patients (1995-2000) were included: age (mean (SD)), 65 (9) years; 55 (48%) male; left atrial diameter 4 (1) cm; left ventricular end diastolic diameter 5 (1) cm; ejection fraction 54 (17)%. Indications for AV node ablation were paroxysmal atrial fibrillation in 95 (83%) and paroxysmal atrial fibrillation/flutter in 19 (17%). The survival curve showed a low overall mortality after 72 months (10.5%). Fifty two per cent of patients progressed to permanent atrial fibrillation within 72 months. There was no difference in progression to permanency between paroxysmal atrial fibrillation and paroxysmal atrial fibrillation/flutter (log rank 0.06, p = 0.8). Logistic regression did not show any association between the variables collected and the development of permanent atrial fibrillation, although age over 80 years showed a trend (p = 0.07). Conclusions: Ablate and pace is associated with a low overall mortality. No predictors of permanent atrial fibrillation were identified, but 48% of patients were still in sinus rhythm at 72 months. These results support the use of dual chamber pacing for paroxysmal atrial fibrillation patients after ablate and pace.",
author = "Andre Queiroga and Howard Marshall and Mairead Clune and Michael Gammage",
year = "2003",
month = sep,
day = "1",
doi = "10.1136/heart.89.9.1035",
language = "English",
volume = "89",
pages = "1035--1038",
journal = "Heart",
issn = "1355-6037",
publisher = "BMJ Publishing Group",
number = "9",

}

RIS

TY - JOUR

T1 - Ablate and pace revisited: long term survival & predictors of permanent atrial fibrillation

AU - Queiroga, Andre

AU - Marshall, Howard

AU - Clune, Mairead

AU - Gammage, Michael

PY - 2003/9/1

Y1 - 2003/9/1

N2 - Objective: To assess long term mortality and identify factors associated with the development of permanent atrial fibrillation after atrioventricular (AV) node ablation for drug refractory paroxysmal atrial fibrillation. Design: Retrospective cohort study. Setting: UK tertiary centre teaching hospital. Patients: Patients admitted to the University Hospital Birmingham between January 1995 and December 2000. Interventions: AV node ablation and dual chamber mode switching pacing. Main outcome measures: Long term mortality and predictors of permanent atrial fibrillation, assessed through Kaplan-Meier curves and logistic regression. Results: 114 patients (1995-2000) were included: age (mean (SD)), 65 (9) years; 55 (48%) male; left atrial diameter 4 (1) cm; left ventricular end diastolic diameter 5 (1) cm; ejection fraction 54 (17)%. Indications for AV node ablation were paroxysmal atrial fibrillation in 95 (83%) and paroxysmal atrial fibrillation/flutter in 19 (17%). The survival curve showed a low overall mortality after 72 months (10.5%). Fifty two per cent of patients progressed to permanent atrial fibrillation within 72 months. There was no difference in progression to permanency between paroxysmal atrial fibrillation and paroxysmal atrial fibrillation/flutter (log rank 0.06, p = 0.8). Logistic regression did not show any association between the variables collected and the development of permanent atrial fibrillation, although age over 80 years showed a trend (p = 0.07). Conclusions: Ablate and pace is associated with a low overall mortality. No predictors of permanent atrial fibrillation were identified, but 48% of patients were still in sinus rhythm at 72 months. These results support the use of dual chamber pacing for paroxysmal atrial fibrillation patients after ablate and pace.

AB - Objective: To assess long term mortality and identify factors associated with the development of permanent atrial fibrillation after atrioventricular (AV) node ablation for drug refractory paroxysmal atrial fibrillation. Design: Retrospective cohort study. Setting: UK tertiary centre teaching hospital. Patients: Patients admitted to the University Hospital Birmingham between January 1995 and December 2000. Interventions: AV node ablation and dual chamber mode switching pacing. Main outcome measures: Long term mortality and predictors of permanent atrial fibrillation, assessed through Kaplan-Meier curves and logistic regression. Results: 114 patients (1995-2000) were included: age (mean (SD)), 65 (9) years; 55 (48%) male; left atrial diameter 4 (1) cm; left ventricular end diastolic diameter 5 (1) cm; ejection fraction 54 (17)%. Indications for AV node ablation were paroxysmal atrial fibrillation in 95 (83%) and paroxysmal atrial fibrillation/flutter in 19 (17%). The survival curve showed a low overall mortality after 72 months (10.5%). Fifty two per cent of patients progressed to permanent atrial fibrillation within 72 months. There was no difference in progression to permanency between paroxysmal atrial fibrillation and paroxysmal atrial fibrillation/flutter (log rank 0.06, p = 0.8). Logistic regression did not show any association between the variables collected and the development of permanent atrial fibrillation, although age over 80 years showed a trend (p = 0.07). Conclusions: Ablate and pace is associated with a low overall mortality. No predictors of permanent atrial fibrillation were identified, but 48% of patients were still in sinus rhythm at 72 months. These results support the use of dual chamber pacing for paroxysmal atrial fibrillation patients after ablate and pace.

U2 - 10.1136/heart.89.9.1035

DO - 10.1136/heart.89.9.1035

M3 - Article

C2 - 12923021

VL - 89

SP - 1035

EP - 1038

JO - Heart

JF - Heart

SN - 1355-6037

IS - 9

ER -